Failure of hormone therapy often involves an outgrowth of protein kinase Ce (PKCe)-positive cells in recurrent prostate cancer. Our previous investigations have uncovered evidence of a complex signaling network operating downstream of this oncogenic protein kinase to actively advance the survival and proliferation of prostate cancer cells. In this study, we present evidence of a functional interplay among integrin receptors, PKCe, and protein kinase B (PKB/Akt) in recurrent CWR-R1 prostate cancer cells. Flow cytometry and confocal microscopy provided evidence that PKCe signaling promoted the assembly of matrix adhesions containing an abundance of colocalized actin filaments and b1 integrins that exhibited an exposed activation epitope on the surface of live CWR-R1 cells. Reciprocal coimmunoprecipitations provided evidence of signaling complexes containing PKCe, b1 integrins, Src, and PKB/Akt in CWR-R1 cell cultures. An investigation into the functional significance of these interactions, and of their positive influence on b1 integrins, demonstrated that PKCe and several key components of the PKB/Akt signaling pathway remain constitutively phosphorylated/activated in adherent but not suspension cultures of PTEN-positive CWR-R1 cells. Gene transfer, antisense and pharmacological experiments provided additional support for the hypothesis that a mutually reinforcing signaling loop sustains the activation of b1 integrins, PKCe, and PKB/Akt in adherent prostate cancer cells.
Introduction
There is a long-standing and sound rationale for the application of androgen deprivation therapy in managing advanced and aggressive prostate cancer (CaP). Still, the remission induced by such therapies is often incomplete and followed by a relapse in which tumor recurrence is accompanied by an androgen-refractory phase for which there is no palliative life-prolonging treatment. Most current strategies for preventing this progression to an androgen-refractory phase have been founded on the understanding that reactivation of certain androgen receptor (AR) signaling pathways, which no longer require ligand (androgen) occupancy of the AR, may be prerequisite for CaP recurrence (Feldman and Feldman, 2001; Culig et al., 2003; Litvinov et al., 2003) . For this reason, there is considerable interest in directly targeting the AR itself, and recent studies confirm that a functional AR is required for androgen-refractory sublines of LNCaP human CaP cells to proliferate at their normal rate in culture (Chen et al., 1998; Eder et al., 2000; Eder et al., 2002; ZegarraMoro et al., 2002) . However, silencing the AR does not inhibit the growth of LNCaP cells overexpressing c-Myc (Bernard et al., 2003) and may not be sufficient to prevent LNCaP tumor growth (Eder et al., 2002) . Several mechanisms, in addition to c-Myc, have now been identified for bypassing the requirement for AR signaling in androgen-and AR-independent CaP cells (Graff, 2002) . This suggests that alternative strategies must be developed for disrupting these AR-independent pathways in order to prevent the outgrowth of androgen-refractory, and often metastatic, clones.
The most commonly mutated cancer genes are those encoding protein kinases (Futreal et al., 2004) . Evidence has mounted that these protein kinases can be effectively manipulated to disrupt the tumorigenic process in a rapidly growing spectrum of human neoplasms (Graff, 2002; Orchard, 2002; Chang et al., 2003; Mackay and Twelves, 2003) . In advanced CaP, the frequent loss of PTEN (also known as MMAC1/TEP-1) expression (McMenamin et al., 1999) makes protein kinases containing a functional pleckstrin homology (PH) domain a logical target for the design of new adjunctive CaP therapeutic agents (Yoganathan et al., 2000; Graff, 2002) . As a lipid phosphatase of the phosphatidylinositol 3-kinase (PI3K) second messengers phosphatidylinositol 3,4-diphosphate (PI(3,4)P 2 ) and PI(3,4,5)P 3 , PTEN suppresses tumor growth by limiting the halflife of these second messengers and their agonistic interactions with the PH domain of at least three oncogenic Ser/Thr protein kinases in the PI3K signaling pathway.
3-Phosphoinositide-dependent kinase-1 (PDK1), integrin-linked kinase (ILK), and protein kinase B (PKB/Akt) all contain PH domains and while both ILK and PKB/Akt have been prominently implicated in the progression of CaP (Persad et al., 2000; Yoganathan et al., 2000; Murillo et al., 2001; Graff, 2002 ) the oncogenic activity of PDK1 has only recently been investigated in breast cancer cells (Xie et al., 2003) . As CaP progresses, PTEN inactivation often advances the biogenesis of a mature phosphorylated and constitutively active PKB/Akt by promoting the colocalization of this enzyme with PDK1 and ILK (reviewed in Alessi, 2001 ). PDK1 directly phosphorylates the activation loop of PKB/Akt (at Thr308), while ILK, which is frequently upregulated and constitutively active in CaP cells (Persad et al., 2000) , facilitates phosphorylation of the PKB/Akt hydrophobic motif (at Ser473; Delcommenne et al., 1998; Persad et al., 2000) . This gain of PKB/Akt function has a well-documented capacity to support CaP cell survival and growth after prolonged androgen deprivation (Murillo et al., 2001) .
b-Catenin is an effector signaling molecule recently implicated in processes of prostate growth and tumorigenesis Gounari et al., 2002) . By directly phosphorylating and inactivating glycogen synthase kinase-3b (GSK-3b, at Ser9), PKB/Akt can prolong the half-life and nuclear accumulation of bcatenin (van Weeren et al., 1998) . Upon entering the nucleus, b-catenin relieves the transcriptional repressor function of T-cell/lymphoid enhancer factor 1 (TCF/ LEF) by displacing corepressors and recruiting coactivators such as cyclic AMP-response element-binding protein, AP-1, and NFkB to its amino-and carboxyterminal transactivation domains (reviewed in Hecht and Kemler, 2000) . Depending on the timing and molecular composition of the cofactors present, transcriptionally active complexes containing b-catenin are capable of targeting a broad spectrum of protooncogenes including promoter regions of cyclin D1, cmyc, and survivin (He et al., 1998; Tetsu and McCormick, 1999 ). An alternative mode of b-catenin nuclear function that could be of fundamental importance in prostate involves the recent finding that b-catenin is able to enhance AR transcriptional activity in a liganddependent fashion Song et al., 2003) . In CaP specimens, nuclear staining for b-catenin has been reported to correlate statistically with Gleason's grade and disease progression (De La Taille et al., 2003) . Moreover, lesions reminiscent of high-grade prostate intraepithelial neoplasia (HG-PIN) have been detected in PTEN þ /À mice and in transgenic mice with prostate-targeted expression of either wild-type PKB1 or a b-catenin mutant that resists proteosomal degradation (Podsypanina et al., 1999; Gounari et al., 2002; Majumder et al., 2003) . These findings place nuclear bcatenin alongside a network of interactive pathway regulators (e.g., AR, the forkhead proteins) and downstream of the oncoprotein PKB/Akt, which, together with a loss of PTEN and gain of ILK function, advances the progression of CaP.
Integrin ligation and clustering have been linked to PKB/Akt and protein kinase Ce (PKCe) activation in adherent cells (Parekh et al., 2000; Lee and Juliano, 2002) . For human b1 integrin, there is substantial evidence that interactions with the matrix are capable of augmenting the extent and duration of PKB/Akt and PKCe substrate phosphorylation by inhibiting protein phosphatase 2A (PP2A) and PTEN (Parekh et al., 2000; Cenni et al., 2002; Pankov et al., 2003) . PKCe reciprocates this positive input by promoting the recycling of internalized b1 integrins back to the cell surface (Ivaska et al., 2002) . Although the oncogenic potential of both PKB/Akt and PKCe has now been established in CaP cells (Murillo et al., 2001; Wu et al., 2002; Wu and Terrian, 2002; McJilton et al., 2003) , their functional relationships to integrin and nuclear bcatenin signaling during CaP progression have not been investigated.
Original descriptions of PKCe immunostaining in CaP tissues were limited to Gleason grade 1-2 neoplasia, where no obvious correlation between staining intensity and malignancy was observed (Cornford et al., 1999) . Our laboratory has since presented immunohistochemical evidence of an outgrowth/clonal selection of PKCepositive cells in recurrent CaP (McJilton et al., 2003) and this observation was rapidly confirmed by others (Korin et al., 2004) . In additional studies, we have found PKCe to be capable of coordinately disrupting the reactivation of the tumor suppressor RB, derepressing transcriptional elongation of the c-myc oncogene, and propagating survival signals in the absence of a functional PTEN protein Wu and Terrian, 2002; McJilton et al., 2003) . We now report that the oncogenic activity of PKCe is not conditional on a loss of PTEN expression in CaP cells and have extended our analysis of its oncogenic activity by investigating the influence of PKCe signaling in an AR-and PTEN-positive CaP cell line (CWR-R1) recently derived from a recurrent CWR22 xenograft (Gregory et al., 2001) . In addition to previously reported aberrations in cellular signaling, we have found PKCe to be capable of controlling the adhesive and spreading properties of CWR-R1 cells by promoting the accumulation of an open/activated conformer of the b1 integrin ectodomain. Importantly, this upregulation of integrin signaling was associated with a constitutive phosphorylation of PKCe and PKB/ Akt that was anchorage-dependent in CWR-R1 cells. This is the first report to approach a bidirectional b1 integrin-PKCe signaling loop from the perspective that it may be capable of supporting the assembly of transcriptionally active b-catenin/TCF complexes through constitutive activation of a canonical PI3K-PKB/Akt pathway.
Results

PKCe positively regulates the shift to an open b1 integrin conformation in CWR-R1 cells
The CWR-R1 cell line was originally derived from a genuine acinar adenocarcinoma (van Bokhoven et al., 2003) and is, therefore, representative of most (495%) human prostate tumors. An additional feature of the CWR-R1 model is that these cells do not require androgens for growth but respond to their presence in culture (Gregory et al., 2001) . Thus, these cells were chosen for the present study because they exhibit an androgen-independent/sensitive phenotype that is observed in more than 90% of CaP cells failing androgen ablation therapy (Linja et al., 2001) .
In fibroblasts, PKCe activity appears to promote the rapid recycling of internalized b1 integrins and their return to the cell surface (Ivaska et al., 2002) . To determine whether PKCe signaling also influences the life cycle of b1 integrins in recurrent CaP cells, we compared the steady-state levels of intracellular b1 integrins, their surface expression, and conformational state in CWR-R1 cells and a stable subline overexpressing PKCe (i.e., CWR-R1/PKCe cells; Figure 1a) . Western blots and a flow cytometric analysis were performed using the pan-b1 integrin antibody M-106 that recognizes the total population of b1 integrins. To probe for meaningful changes in the b1 integrin conformer, we used a monoclonal antibody (9EG7) that binds an epitope (residues 495-602) in the integrin stalk that is exposed only in ligand-competent receptor conformers (Bazzoni et al., 1998) . Cells incubated with fluorescein isothiocyanate (FITC)-conjugated secondary antibodies alone served as controls for immunospecificity. The comparisons shown in Figure 1 indicate that ectopic expression of PKCe in CWR-R1 cells increased both the overall level of b1 integrin proteins ( Figure 1a ) and the mean fluorescence intensity (MFI) of b1 integrin staining with the pan-b1 integrin antibody M-106 in the absence (control; Figure 1b) but not in the presence of the PKC inhibitor bis-indolylmaleimide I (BIM; Figure 1b ). Under control conditions, the MFI of specific M-106 staining (versus the secondary antibody control; MFI ¼ 2.871.4) was negligible for CWR-R1 (MFI ¼ 4.372.1) and increased by more than twofold in CWR-R1/PKCe cells (MFI ¼ 10.371.6). In the presence of BIM, no specific M-106 staining was detected for either cell line (MFI ¼ 1.970.9, 2.171.2, and 3.771.8 for antibody controls, CWR-R1, and CWR-R1/PKCe; respectively). Significantly, the data also demonstrated that PKCe was capable of inducing a powerful shift in the conformational equilibrium of b1 integrins. Compared to CWR-R1 parentals, CWR-R1/PKCe cells (c) Equal numbers of CWR-R1 and CWR-R1/PKCe cells were seeded on fibronectin-coated glass coverslips (10 mg/ml) for 3 h prior to removing unattached cells with three rinses in PBS and evaluating cell adhesion by staining the remaining cells with crystal violet and measuring absorbance at 570 nm. Data are the means (7s.e.) of triplicate determinations in three independent experiments. (d) Cell spreading was evaluated after equal numbers of CWR-R1 and CWR-R1/PKCe cells were allowed to adhere to fibronectin-coated glass coverslips (10 mg/ml) overnight. Cells were scored as positive (well-spread) if the membrane periphery extended outward by at least twice the nuclear diameter, as viewed using a Â 25 objective under phase contrast microscopy. Data represent the mean percentage of 300 cells scored as 'spread' (7s.e.) counted in triplicate in two independent experiments Integrin signaling in prostate cancer cells D Wu et al displayed a ninefold increase in the abundance of the high-affinity, 9EG7-positive epitope for b1 integrin on the cell surface (Figure 1b ; MFI ¼ 3.271.4, 32.271.9, and 28576.4 for antibody controls, CWR-R1, and CWR-R1/PKCe; respectively). This relative increase in the intensity of 9EG7 staining was sustained in subconfluent cultures of CWR-R1/PKCe cells that had been plated for 12-48 h in complete medium. However, in the presence of BIM, the intensity of 9EG7 staining was decreased by B70% in both cell lines (Figure 1b ; MFI ¼ 1. 871.2, 8.171.4, and 90.372 .5 for antibody controls, CWR-R1, and CWR-R1/PKCe; respectively). Although BIM inhibits a variety of PKC isozymes, the observed decreases in the surface expression of M-106 and 9EG7-positive epitopes were consistent with the suggestion that PKCe activity may be required for b1 integrins to efficiently recycle to the cell surface (Ivaska et al., 2002) . However, the strong positive influence that PKCe signaling exerted on the accumulation of an open (active) b1 integrin conformer had not previously been described. Until now, only PKCa was known to possess the ability to control both the trafficking and activation state of b1 integrins (Ng et al., 1999) . Although CWR-R1/PKCe cells expressed an increased overall level of b1 integrins (Figure 1a) , this is not likely to account for the observed gain of b1 integrin affinity/avidity. First, the majority of b1 integrins do not localize to the cell surface of CaP cells (Fonaro et al., 2001) and, second, the intensity of 9EG7 staining in nonpermeabilized cells does not correlate with changes in the bulk levels of b1 integrin expression (Bazzoni et al., 1998) . Interestingly, this influence of PKCe on the 'shape' of b1 integrins may not be evident in all cell types, as the surface expression of these receptors was not altered by the re-expression of PKCe in mouse embryo fibroblasts (MEFs) of a PKCe À/ À embryo (Ivaska et al., 2002) .
PKCe modulates organization of cell matrix adhesions that CWR-R1 cells form on fibronectin
Because fibronectin is a suitable substrate for any b1 integrin heterodimer that CaP cells have been reported to express (Fonaro et al., 2001) , with the exception of a6b1 (a laminin receptor), we compared the adhesion and spreading of CWR-R1 and CWR-R1/PKCe cells using fibronectin-coated glass coverslips. When seeded for 3 h, 78% of the CWR-R1 cells overexpressing PKCe remained attached after repeated washing, compared with 41% of the parental controls ( Figure 1c ). Saturating concentrations (100 mg/ml) of anti-human b1 integrin function blocking antibodies (clone 6S6) inhibited the adhesion of either cell line by more than 85% under these conditions (data not shown). In addition, a majority (475%) of CWR-R1/PKCe cells also spread on fibronectin (as defined in Materials and methods), compared with less than 10% of the CWR-R1 cells, during a 12 h incubation ( Figure 1d ). These results were consistent with previous reports that PKCe signaling positively regulates cell adhesion and spreading in an assortment of cell lines (Chun et al., 1996; Berrier et al., 2000) .
When serum-starved CWR-R1 cells were allowed to attach and spread on fibronectin for 12 h, a loosely organized cortical ring of F-actin (phalloidin : rhodamine) was observed and 9EG7-immunoreactive b1 integrins were clustered in focal contacts that localized to cell apices or protrusions (Figure 2 ). In comparison, nonpermeabilized CWR-R1/PKCe cells typically displayed an abundance of 9EG7-positive b1 integrins that extensively colocalized with F-actin in peripheral matrix adhesions, formation of stress fibers/bundles, exaggerated spreading, and a polarized ('motile') cell shape that often included a prominent forward lamellipodia and trailing retraction tail (Figure 2 ). These marked changes in the dynamics of CWR-R1 cell adhesion, spreading, cytoskeletal organization, and shifts in the conformer equilibrium of b1 integrins could reflect the activity of a dominant inside-out signaling pathway in which PKCe functions upstream of certain Rho family GTPases and b1 integrins. Although the influence of these changes in b1 integrin activity have been extensively studied in models of cell motility, their potential role in propagating the oncogenic signals that PKCe generates in CaP cells had not been investigated.
Integrin-mediated adhesion is required for PKCe to activate PKB/Akt in CWR-R1 cells
In a functional proteomic analysis of PKCe immunoprecipitates, this laboratory recently identified PKB/Akt as a component of at least one of the multimeric signaling complexes that associate with PKCe in recurrent CWR22 tumors in vivo (McJilton et al., 2003) . Reciprocal coimmunoprecipitation assays have extended this finding by demonstrating that an endogenous pool of PKCe interacts with PKB/Akt, and PKB/Akt binds to PKCe, in subconfluent cultures of the parental CWR-R1 cell line ( Figure 3a ). To determine whether these oncogenic protein kinases were functionally interactive, we have tested the hypothesis that PKCe signaling may influence the phosphorylation/activation of PKB/Akt through an 'outside-in' pathway involving the transduction of signals from integrin receptors to PI3K and the PI(3,4,5)P 3 -binding proteins PDK1 and ILK. Recent studies provide strong support for such a model (Parekh et al., 2000; Persad et al., 2000; Yoganathan et al., 2000; Lee and Juliano, 2002; Pankov et al., 2003) and there is now good reason to consider the possibility that such a pathway could support bidirectional signaling between PKCe, an established substrate of PDK1, and b1 integrins. A combination of gene transfer, antisense and pharmacological experiments provided convincing evidence that PKCe may be of importance in regulating PKB/Akt activity and the proliferation of CWR-R1 cells. When compared to the parental controls in adherent cultures, ectopic expression of PKCe clearly accelerated the growth of CWR-R1 cells ( Figure 3b ). As CWR-R1 cells express a full-length (54 kDa) PTEN protein (Figure 3c ), the ability of PKCe to accelerate the growth of CaP cells did not appear to be conditional on a loss of PTEN expression. However, other analyses revealed that the effects of PKCe on PKB/Akt phosphorylation were conditional on cell adhesion. In adherent cultures of CWR-R1 cells, the hydrophobic motif (Ser729) of PKCe remained constitutively phosphorylated ( Figure 3d , top panel) and PKCe overexpression increased the basal levels of PKB/Akt phosphorylation on both Thr308 and Ser473 without altering the expression of endogenous PKB/Akt or PTEN ( Figure 3c ). To determine whether the positive influence of PKCe expression on b1 integrin ligandbinding competence and PKB/Akt phosphorylation were functionally coupled, we compared adherent and suspension cultures of CWR-R1 and CWR-R1/PKCe cells. Integrin disengagement was sufficient to induce an accumulation of the dephosphorylated forms of both PKCe (on Ser729) and PKB/Akt (on Ser473) in CWR-R1 cells (Figure 3d ). Unlike HEK-293 cells (Parekh et al., 2000) , the reintroduction of serum in suspension Antisense experiments provided additional and independent evidence that endogenous PKCe was required for CWR-R1 cells to maintain their normal rate of proliferation and phosphorylation of PKB/Akt on Ser473 (Figure 3e ). In agreement with a previous report , the antisense PKCe oligodeoxynucleotide (ODN) used in this study selectively and effectively downregulated translation of PKCe mRNA without altering the expression of controls such as PKCa or ERK (Figure 3e ). To determine whether the growth advantage imparted by PKCe overexpression was dependent on PI3K activity, we compared the growth of CWR-R1 and CWR-R1/PKCe cultures in the presence of a specific inhibitor of PI3K (LY294002). LY294002 (10 mM) significantly inhibited the growth of CWR-R1 cells by 39% and the efficacy of this agent was markedly enhanced in cells overexpressing PKCe, whose growth was inhibited by 77% (Figure 4a ). In a separate experiment, inhibitors of PKB/Akt and ERK kinase (MEK-1) were tested to determine whether these agents would interact to further inhibit the growth of untransfected CWR-R1 cells. Ectopic expression of PKCe is associated with activation of MAPK/ERK in CWR-R1 and LNCaP cells Wu and Terrian, 2002) . Both LY294002 (10 mM) and SH-6 (20 mM), an inhibitor of PKB/Akt membrane translocation and activation (Meuillet et al., 2003) , significantly decreased CWR-R1 cell growth by 35 and 64%, respectively (Figure 4b ). The MEK-1 inhibitors PD98059 (50 mM) and U0126 (10 mM) inhibited cell growth by 23 and 27%, respectively. When combined, SH-6 and U0126 inhibited growth by 85% (Figure 4b ). Thus, a repertoire of integrin-mediated signals (PI3K-PKB/Akt and MAPK/ERK) and downstream effector molecules may be required to propagate the full oncogenic activity of PKCe and sustain the growth of human CaP cells. An indication that b1 integrin engagement may support the growth of CWR-R1 cells was also provided by the finding that the growth of cultures incubated in the presence of an anti-human b1 integrin adhesion blocking mAb was significantly inhibited (Figure 4b ).
Evidence that Src and ILK may operate 'downstream' of PKCe
Intramolecular interactions normally maintain Src kinases in an autoinhibited conformation (Schaller et al., 1994) . A conventional mechanism for overcoming these restraints and recruiting an Src kinase to integrin- (Schaller et al., 1994) . Src kinases can also be activated by direct interactions with b integrin cytodomains (Arias-Salgado et al., 2003) or b1 integrin may indirectly facilitate Src activation by sequestering PP2A into an inactive aggregate (Pankov et al., 2003) . Interestingly, PP2A has also recently been implicated in the control of PKCe dephosphorylation in response to cytokine signaling (Ivaska et al., 2003) . However, okadaic acid (OA), an inhibitor of PP2A and protein phosphatase 1 (PP1), did not augment the basal phosphorylation of PKB/Akt (at Ser473) in adherent cultures of CWR-R1 cells (Figure 5a ). Conversely, inhibitors of Src kinase (PP2) and PI3K (LY294002) both suppressed PKB/Akt phosphorylation (Figure 5a ). Thus, both Src and PI3K appear to be of importance in transducing signals from PKCe and b1 integrins to PKB/ Akt in adherent CWR-R1 cells, while, under these conditions, neither PP1 nor PP2A appears to counterbalance the influence of these positive inputs to PKB/Akt. Although the RACK1 protein appears to serve as a scaffold for both PKCe and b1 integrins in glioma cells (Besson et al., 2002; Hermanto et al., 2002) , such interactions were not detected in CWR-R1 lysates containing substantial amounts of the RACK1 protein (Figure 5b) . Rather, our analysis of immunoprecipitates isolated from CWR-R1 cell lysates indicated that endogenous PKCe reciprocally interacts with PKB/ Akt, Src, and ILK (Figures 3a and 5b) . Evidence that ILK may function downstream of PKCe to promote PKB/Akt phosphorylation was obtained in transient transfection assays, which demonstrated that a dominant-negative form of ILK (ILK E359K; Yoganathan et al., 2000) suppressed the phosphorylation of PKB/ Akt (on Ser473) in CWR-R1/PKCe cells (Figure 5c ). Other mutual interactions that have been observed in parental CWR-R1 cells included an association of b1 integrin with Src and talin (Figure 5b ). Although b1 integrin was present in PKCe immunoprecipitates, the reverse pull-downs did not contain PKCe (not shown). Thus, our search for a common scaffold/anchoring protein remains incomplete but the evidence available suggests that Src, PI3K, and ILK may be of importance in transducing certain signals from PKCe and b1 integrins to PKB/Akt in human CaP cells.
PKCe strengthens TCF/b-catenin transcriptional activity in CWR-R1 cells
When activated by extracellular cues, such as integrin engagement of the extracellular matrix, PKB/Akt Figure 6 PKCe promotes the nuclear accumulation of b-catenin. (a) Cell lysates were isolated from subconfluent cultures of CWR-R1 and CWR-R1/PKCe cells and analysed for endogenous GSK3b, phosphorylated GSK-3b (Ser9), b-catenin, E-cadherin, and total ERK1/2 (loading control) by immunoblotting using appropriate antibodies. Nuclear extracts (50 mg/lane) were also analysed by immunoblotting for nuclear b-catenin (nuc. b-catenin). Immunoblots shown are representative of two independent experiments. (b) Subconfluent cultures of CWR-R1 cells were exposed to Lipofectin alone (Cont.), Lipofectin plus 2 mM of a scrambled control (SC) PKCe ODN, or 2 mM antisense (AS) PKCe ODN for 3 days. Cell lysates were then analysed for endogenous GSK-3b, phosphorylated GSK-3b (Ser9), b-catenin, and total ERK1/2 (loading control) by immunoblotting. Nuclear extracts (80 mg/lane) were also analysed by immunoblotting for b-catenin. Results are representative of two independent experiments. (c) CWR-R1 cells were treated with 10 mM SH-6, 10 mM LY294002, or 10 mM LiCl for 24 h. Nuclear extracts (80 mg/lane) were then analysed for nuclear b-catenin by immunoblotting. Results are representative of two independent experiments. (d) Subconfluent cultures of CWR-R1 and CWR-R1/PKCe cells were transiently transfected with pTOPFlash or pFOP-Flash, and pTK-RL was used as an internal control, according to the manufacturer's instructions. At 48 h after transfection, CWR-R1/PKCe cells were treated with or without 10 mM LY294002, as indicated, for 6 h. Cell lysates were assayed for luciferase activity and the relative activity was defined as the ratio of luminescence in cells transfected with TOF-Flash versus FOPFlash plasmids. Results are the means7s.e. of triplicate determinations and are representative of three independent experiments. (e) Subconfluent cultures of CWR-R1 cells were exposed to Lipofectin alone (Cont.), Lipofectin plus 2 mM scrambled control (SC) PKCe ODN, or 2 mM antisense (AS) PKCe ODN. After 48 h, cells were transiently transfected with pTOP-Flash or pFOP-Flash, and pTK-RL plasmids, as in (d). At 48 h after transfection, cell lysates were assayed for luciferase activity. Where indicated, cells were pretreated with 10 mM LY294002 for 6 h, or 10 mM LiCl for 24 h, before measuring luciferase activity. Results are the means7s.e. of triplicate determinations and are representative of three independent experiments Integrin signaling in prostate cancer cells D Wu et al modulates the function of many effector molecules involved in processes that include gene expression, metabolism, and survival (for review, see Chang et al., 2003) . We have examined the influence of PKCe signaling on several of these downstream responses to PKB/Akt activation. For clarity, however, we present only the evidence that PKCe promotes the nuclear accumulation of b-catenin and transactivation of a TCF/b-catenin-responsive (TOP) construct in CWR-R1 cells. Activation of the b-catenin pathway could account for the pronounced increases in cyclin D1 and c-Myc expression we have previously observed in LNCaP cells overexpressing PKCe Wu and Terrian, 2002) and may directly contribute to CaP progression and recurrence Gounari et al., 2002; De La Taille et al., 2003) .
Evidence that PKCe expression influenced the activity of GSK-3b, nuclear accumulation of b-catenin, and expression of E-cadherin is presented in Figure 6 . In subconfluent cultures of CWR-R1/PKCe cells, basal levels of GSK-3b (Ser9) phosphorylation were substantially elevated in comparison to untransfected controls, indicating that GSK-3b was inhibited (Figure 6a ; Van Weeren et al., 1998) . This was accompanied by a loss of E-cadherin expression and a marked increase in the level of nuclear b-catenin (Figure 6a ), both of which are observed in metastatic and hormone-refractory CaP cases Gounari et al., 2002) . Based on these results, along with evidence that GSK-3b promotes b-catenin degradation and E-cadherin protects b-catenin from such enzymes by sequestering the soluble protein to the membrane (Wong and Gumbiner, 2003) , we inferred that PKCe may coordinately repress GSK-3b activity and E-cadherin expression in a manner that permits enhanced nuclear accumulation of bcatenin.
To determine whether the PKCe that is naturally expressed by CWR-R1 cells also influences the activity of the b-catenin pathway, antisense experiments targeting PKCe transcripts were repeated. These studies provided independent support for the hypothesis that this oncogenic protein kinase is required to repress the basal levels of GSK-3b activity and nuclear accumulation of b-catenin. When treated with the same antisense PKCe ODN used in Figure 3e , the suppression of PKCe translation was associated with decreased levels of GSK3b (Ser9) phosphorylation and nuclear b-catenin in adherent cultures of CWR-R1 cells (Figure 6b) , again satisfying the concept that PKCe supports the constitutive activation of a b-catenin signaling pathway in human CaP cells. Moreover, although reciprocal changes in GSK-3b (Ser9) phosphorylation and the intracellular distribution of b-catenin were associated with PKCe overexpression and antisense PKCe ODN treatments in CWR-R1 cells, the steady-state levels of the proteins themselves were not altered in whole-cell lysates (Figures 6a and b) . Inhibitors of PI3K (LY294002), PKB/Akt (SH-6), and GSK-3b (LiCl) provided additional evidence that a constitutively active PI3K-PKB/Akt pathway controls b-catenin nuclear accumulation/activity in adherent cultures of CWR-R1 cells. Whereas LY294002 and SH-6 both decreased, LiCl increased the basal levels of nuclear b-catenin in these untransfected CWR-R1 cells (Figure 6c ).
Ectopic expression of PKCe increased the transcriptional activity of TCF/b-catenin by several-fold when tested on the TOP/FOP-Flash reporter system in CWR-R1 cells and this activity was controlled by PI3K because it was blocked by LY294002 (Figure 6d) . Data generated by these assays are presented as ratios of the activity measured using the same synthetic promoter containing either functional (TOP) or mutated (FOP) TCF-binding elements. In untransfected CWR-R1 cells, LY294002 inhibited the basal activity of this reporter by B40% and LiCl augmented its activity by B85% (Figure 6e) , consistent with the notion that PKB/Akt and GSK-3b operate upstream of b-catenin to control TCF/b-catenin signaling in CWR-R1 cells. To determine whether PKCe activity also participated in the regulation of such a b-catenin signaling pathway, reporter assays were repeated using CWR-R1 cells that had been pretreated with control or antisense PKCe ODN according to our standard protocol . As expected from previous work (Figures 4-6) , the scrambled control ODN did not alter reporter activity while the antisense PKCe ODN decreased basal activity by B70% (Figure 6e ). When taken in conjunction with reports that most CaP cell lines express TCF4, but little or none of the three other TCF/LEF transcription factors (LEF, TCF1, and TCF3; , the present data imply that PKCe is required to sustain the normal basal level of constitutive TCF4/b-catenin transcriptional activity in adherent cultures of CWR-R1 cells.
To extend our findings, we questioned if the TOP/ FOP-Flash reporter system had provided an accurate reflection of the TCF/b-catenin activity that occurs with natural target gene promoters in CaP cells. As an example, c-Myc and cyclin D1 were selected for this inquiry because their promoters contain authentic TCF/ LEF-binding sites (Tetsu and McCormick, 1999; Bernard et al., 2003) and each has a fundamental role in controlling CaP cell growth (Drobnjak et al., 2000; Wu et al., 2002; Wu and Terrian, 2002) . As shown in Figure 7 , ectopic expression of PKCe increased the steady-state levels of both c-Myc (Figure 7a ) and cyclin D1 (Figure 7b ) in adherent cultures of CWR-R1 cells. Conversely, basal levels of both proteins were decreased in CWR-R1 cells pretreated with antisense PKCe ODN (Figures 7a and b) . Moreover, a comparison of phospho-GSK-3b (Ser9), nuclear b-catenin, and cyclin D1 expression in adherent versus suspension cultures of CWR-R1 cells demonstrated that all three indices of TCF/b-catenin activity were reduced when CWR-R1 cells were held in suspension overnight (Figure 7c ). Importantly, a loss of cell viability did not appear to account for the various changes that have been observed in CWR-R1 suspension cultures (Figure 7d ). These observations indicated that endogenous b1 integrins and PKCe may operate upstream of PKB/Akt to strengthen the activity of TCF4/b-catenin transcriptional complexes in adherent cultures of CaP cells. However, the data do not exclude the possibility that PKB/Akt activity may have also prompted an accumulation of cyclin D1 protein by inhibiting the GSK-3b-induced proteolysis of cyclin D1 (Diehl et al., 1998) .
Recurrent growth of CWR22 xenograft tumors is associated with alterations in the expression profile of the PKCe-PKB/Akt signaling pathway Analysis of gene expression profiles in human CWR22 CaP xenografts have provided support for the hypothesis that a cluster of genes, functionally related to PI3K-PKB/Akt cascades, become reactivated in CaP that recurs after prolonged androgen deprivation therapy in vivo (Mousses et al., 2001) . Now that there is evidence that changes in PKCe expression may be functionally linked to an activation of the PI3K-PKB/Akt pathway in CWR-R1 cell cultures, we questioned whether an in vivo failure of hormone therapy could also be linked to meaningful changes in protein expression. Western blot analyses of tumor lysates isolated from androgendependent (primary) tumors were compared to rapidly regressing tumors, taken 6 days after castration, and tumors recovered during the initial (112 and 120 days after castration) and recurrent stages of hormonerefractory tumor growth (Figure 8 ). Evidence of a clonal selection for PKCe-positive cells in recurrent CaP has recently been presented (McJilton et al., 2003) and, in agreement with this report, we found that the expression of PKCe was initially diminished after castration and then progressively increased during the course of recurrent tumor growth (Figure 8 ). Although PTEN expression often decreases in recurrent CaP, this was not observed in the present study. Rather, PTEN expression peaked at 6 days postcastration and gradually returned to precastration levels in the recurrent CWR22 tumors. We observed no real change in the steady-state levels of PDK1, while the levels of ILK expression increased upon castration and remained elevated throughout the course of these experiments. PKB/Akt expression was higher in recurrent CWR22 tumors than in the primary tumors, and this gain of PKB expression has also recently been documented in advanced cases of CaP, where the intensity of PKB/Akt immunostaining is reported to correlate with Gleason's grade (Liao et al., 2003) . Downstream of PKB/Akt, there was an upregulation of cyclin D1 in recurrent CWR22 tumors, while c-Myc was consistently diminished after castration and then recovered (Figure 8) . Finally, although both PKCa and PKCd have the potential to function as tumor suppressors in CaP (Tanaka et al., 2003) , we observed no consistent changes in the expression of either protein during the course of tumor regression and regeneration. We propose that this overall profile of changes in protein expression makes the CWR22 xenograft model an 
Discussion
Failure of hormone therapy in CaP is often accompanied by a loss of PTEN function (McMenamin et al., 1999) . This important realization fostered an urgent push to understand how a shift toward ungoverned PKB/Akt activity might alter the fate of CaP cells and focused interest in disease-specific controls over the canonical PI3K-PKB/Akt pathway. We have shown that CaP cells expressing PKCe are likely to survive hormone therapy (McJilton et al., 2003) and now introduce evidence that mutually reinforcing interactions among PKCe and b1 integrin signaling pathways may be capable of supporting the growth/survival of PTEN-positive CaP cells. These reciprocal interactions between b1 integrins and PKCe have previously been described (Parekh et al., 2000; Ivaska et al., 2002) ; however, their relationship to PKB/Akt and oncogenesis in CaP were not considered. Our study is the first to demonstrate that PKCe, Src, ILK, and PKB/Akt associate in CWR-R1 cells and that integrin engagement may be sufficient to activate this multikinase complex and sustain PKB/Akt signaling to TCF/b-catenin transcriptional complexes and possibly additional downstream effectors of PKB/Akt. Moreover, we have uncovered evidence that crucial determinants of PKB/ Akt function (PKCe, ILK, and PKB/Akt) are coordinately upregulated at different times after castration in the CWR22 model of recurrent CaP. These studies further illustrate the key role that PKCe and PKB/Akt may play in recurrent CaP and reinforce the notion that such oncogenic protein kinases could be effectively targeted to enhance the efficacy of hormone therapy.
The epitope recognized by mAb 9EG7 maps to a Cysrich repeat (residues 495-602; Bazzoni et al., 1998) within the b1A integrin extracellular stalk that propagates signals from the membrane to the ligand-binding headpiece (Beglova et al., 2002) . According to the switchblade model for integrin unfolding, exposure of this 'activation' epitope is thought to result from shape changes that take place during receptor activation (Beglova et al., 2002) . Therefore, PKCe signaling appears to have stabilized an extended (active) conformation of b1 integrins within matrix adhesions on the surface of CWR-R1 cells. To produce such a long-range allosteric change in the extracellular domains of integrin heterodimers by inside-out signaling generally appears to involve a physical separation of a and b cytoplasmic domains (for review, see Hynes, 2002) . In the case of the platelet integrin, aIIbb3, there is convincing evidence that proteins containing phosphotyrosine-binding (PTB) domains, such as talin, may disrupt these interdomain interactions by binding the NPxY motif conserved in the cytoplasmic domains of most integrin b subunits (Hynes, 2002) . Our studies introduce the idea that PKCe signaling can be positively linked to robust interactions between 9EG7-positive b1 integrins and the extracellular matrix and emphasize the importance of addressing the basic question of how PKCe might destabilize integrin ab tail associations. Fornaro et al. (2003) recently concluded that b1 integrin interactions with fibronectin promote the survival of CaP cells by activating PKB/Akt and genomic targets of TCF/b-catenin; our data concur. Moreover, based on evidence that CaP cells coordinately downregulate b1C integrin expression, an antiproliferative variant of the receptor subunit, and grow more reliant on b1A for adhesion and proliferation (Moro et al., 2004) , we hypothesize that PKCe may selectively signal to the cytoplasmic tail of b1A integrin. Many integrins can positively regulate PKB/Akt by promoting assembly of an active tyrosine kinase (e.g., FAK and Src)-PI3K complex or, in the case of the b1A subunit, by sequestering PP2A into a localized and inactive aggregate (Pankov et al., 2003) . Our data provide evidence favoring a novel model in which PKCe and b1 integrins mutually interact to enhance the constitutive phosphorylation/activity of PKB/Akt, which many CaP cells come to rely on for survival (Murillo et al., 2001) , via an Src kinase-PI3K pathway that is independent of PP2A and the RACK1 scaffolding protein.
Intramolecular interactions normally maintain Src kinases in an autoinhibited conformation that can be relieved by recruiting an Src kinase to b1 integrin-FAK signaling complexes. Upon integrin ligation, FAK autophosphorylation on Tyr397 provides a docking site for the Src SH2 domains (Schaller et al., 1994) . Transautophosphorylation of the Src activation loop on Tyr416 and dephosphorylation of Tyr527 then allow Src kinases to switch to a stable activated state within focal adhesions (Schaller et al., 1994) . However, our immunofluorescence studies indicate that 9EG7-positive b1 integrins may not be localized to focal adhesions or activated FAK (data not shown) in adherent CWR-R1 cells. Therefore, additional mechanisms of PKCeinduced Src activation should be considered. For example, there is now evidence that Src kinases can be activated by direct interactions with the cytoplasmic domain of b integrins (Arias-Salgado et al., 2003) . Although many important details such as those discussed above remain to be established, it now seems clear that PKCe is positioned within the overall pathway to promote Src kinase interactions with b integrins. recently postulated that PKB/Akt might not be an important regulator of TCF/b-catenin transcriptional activity in human CaP cells because of a failure to show inhibition of the TOP/FOP reporter construct by LY294002 in their model system. We concur that the inhibition produced by LY294002 was modest (Figure 6e ), but, more significantly, we have demonstrated that the powerful influence that PKCe exerts on TCF/b-catenin transcriptional activity is completely neutralized by this inhibitor of PI3K in CWR-R1/PKCe cells (Figure 6d ). It must also be stressed that a positive link between PKB/Akt and b-catenin nuclear signaling in CaP has now been supported by the work of at least two other laboratories (Persad et al., 2001; Sharma et al., 2002) . In the present study, we have uncovered new evidence, which suggests that the positive influence that PKCe exerts on PKB/Akt has the potential to significantly enhance the activity of TCF4/b-catenin in adherent cultures of CWR-R1 cells.
The results presented in this study indicate that a mutual activation of b1 integrins and PKCe signaling could clearly contribute to the establishment of a constitutively activate PI3K-PKB/Akt pathway in PTEN-positive CaP cells. This and other recent investigations on PKCe signaling Wu and Terrian, 2002; McJilton et al., 2003) demonstrate that multiple effector signaling pathways must participate in generating the phenotypic responses of CaP cells to PKCe-mediated activity, including the Raf-MAPK-ERK kinase cascade, the RB-E2F pathway, the PI3K-PKB/Akt pathway, and mitochondrial-dependent apoptosis pathways. The influence of PKCe expression on stress fiber formation and b1 integrin clustering has not been described previously. Recently, interests in exploiting the unique patterns of integrins expressed on tumor cells for recognition by immune-based cytotoxins have turned to efforts for targeting integrins themselves (Tucker, 2002) . Concurrently, inhibitors of ILK and PKB/Akt are proving to be effective chemotherapeutic targets in solid tumors, including prostate (Yoganathan et al., 2000; Chang et al., 2003) . Understanding how bidirectional signaling links b1 integrins to PKCe and the PKB/Akt survival pathway should provide many valuable insights into the development of such treatments.
Materials and methods
Cell lines and culture conditions
The CWR-R1 cell line was cultured in Richter's improved minimal essential medium (IMEM Divitrogen) supplemented with 100 ng/ml epidermal growth factor (Becton Dickinson Labware, Franklin Lakes, NJ, USA), 10 mg/ml insulin/ transferrin/selenium (BD Biosciences, Bedford, MA, USA), 10 mM nicotinamide, 900 ng/ml linoleic acid (Sigma, St Louis, MO, USA), 100 U/ml penicillin, 100 mg/ml streptomycin, and 2% FBS. CWR-R1 cells overexpressing wild-type PKCe (CWR-R1/PKCe) were constructed as described previously . To avoid artifacts caused by clonal selection, the polyclonal populations of stable transfectants were used in all experiments. Cell suspensions were prepared using subconfluent cultures and maintained in suspension by rotation for 24 h at 371C in serum-free medium. Cultures were then treated with (10 mM) or without the PI3K inhibitor LY294002 (Calbiochem, San Diego, CA, USA) for 4 h before stimulation with or without 2% FBS, for a further 30 min, according to Parekh et al. (2000) . Where specified, adherent CWR-R1 or CWR-R1/PKCe cells were treated with pharmacological/chemical inhibitors of PKC (BIM; Calbiochem, San Diego, CA, USA), Src (PP2; Calbiochem), PKB/Akt (SH-6; Alexis, San Diego, CA, USA), MEK-1 (PD98059 or U0126; Calbiochem), PP1/PP2A (OA; Sigma), or GSK-3b (LiCl) or treated with the anti-human b1 integrin adhesion blocking mAb, clone 6S6 (Chemicon Intl, Temecula, CA, USA), prior to plating.
Cell adhesion
Cells (1 Â 10 5 ) were seeded for 3 h at 371C in complete medium in six-well plates precoated with 10 mg/ml fibronectin (Becton Dickinson). As a control, cells were preincubated for 30 min in the presence of 50 mg/ml anti-b1 integrin adhesion blocking mAb (clone 6S6). Each well was washed three times with phosphate-buffered saline (PBS) containing 0.9 mM CaCl 2 and 0.5 mM MgCl 2 to remove nonadherent cells and stained with 0.2% crystal violet for 5 min at room temperature. After washing an additional three times with PBS to remove unbound stain, equal aliquots of a 50 mM NaH 2 PO 4 (pH 4.5) and 25% EtOH solution were added to each well and absorbency was measured at 570 nm using a Microplate Scanning Spectrophotometer (Bio-Tek Instruments, Vermont, USA).
Cell spreading
Cells were seeded onto Labtek chamber slides (Nalge Nunc Int'l) precoated with 10 mg/ml fibronectin and incubated in complete medium overnight prior to fixation in 3.7% paraformaldehyde (20 min). Phase contrast microscopy, under a phase 2 Â 25 objective on a Photomic III light microscope (Zeiss, Jena, Germany), was used to visually examine 300 randomly selected cells in three nonoverlapping fields. Cells were scored as either spread or not using the operational criteria that the membrane boundary of a 'spread' cell must be extended, over the majority of its circumference, to at least twice the diameter of its nucleus.
Flow cytometry
Adherent cells were detached with trypsin and diluted to 1 Â 10 6 cells/ml in Richter's IMEM (Zn 2 þ ) medium. Aliquots (1 ml) of each cell suspension were incubated with 2 mg of total rabbit anti-human b1 integrin (M-106; Santa Cruz) or 5 mg of rat monoclonal antibody (mAb) 9EG7 (Pharmingen) for 1 h at 41C. Stained cells were washed twice in PBS and incubated with 10 mg of the appropriate FITC-conjugated secondary antibody for 1 h at 41C. Cells incubated with FITC-conjugated secondary antibodies alone served as controls for immunospecificity. Cells were washed and resuspended in PBS before analysis using a FACScan flow cytometer (Becton Dickinson, Lincoln Park, NJ, USA).
Immunofluorescence microscopy
Immunohistochemical staining was performed as described by McJilton et al. (2003) . Briefly, cells were plated on acid-washed German glass coverslips coated with 10 mg/ml fibronectin (Santa Cruz) and incubated for 12 h in complete Richter's IMEM medium. Cells were washed with PBS, fixed in 3.7% paraformaldehyde (20 min) and blocked in 1% bovine serum albumin (BSA) for 1 h. Immunostaining was performed using 10 mg/ml rat anti-mouse 9EG7 b1 integrin antibody alone, or costained with 4 mg/ml rabbit anti-human PKCe antibody (Santa Cruz), in 1% BSA for 1 h at room temperature. After three washes in PBS, all coverslips were incubated in the dark with 8 mg/ml anti-rat IgG-FITC alone or coincubated with 15 mg/ml anti-rabbit IgG Rhodamine Red-X (Jackson ImmunoResearch) for 40 min at room temperature. All coverslips were rinsed a final time with PBS and affixed to glass microscope slides using Prolong anti-fade fixative (Molecular Probes). Cells were examined for immunofluorescence using an LSM 510 confocal microscope (Zeiss, Jena, Germany) and LSM 5 Image Examiner software. Control slides were incubated with equimolar concentrations of secondary antibody alone and showed no immunoreactivity.
Antisense oligodeoxynucleotide treatments
Phosphorothioate ODNs were obtained from Invitrogen (Carlsbad, CA, USA). Sequences for the antisense PKCe ODNs and the corresponding scrambled control were exactly as specified . CWR-R1 cells were treated with ODNs as described previously . Briefly, subconfluent (50-60%) cultures were washed with Opti-MEM 1 (Invitrogen) before introducing a mixture of ODN and Lipofectin (5 mg/ml). After 6 h at 371C, cells were washed twice with Opti-MEM 1 and incubated for 18 h in Lipofectin-free medium containing ODN and 2% FBS. The medium was replenished, and the cells were incubated for an additional 3 days in complete medium containing ODN.
Transient transfection
A eukaryotic expression plasmid (pcDNA3.1/V5-HisA) under the control of the CMV promoter, and containing a dominantnegative form of ILK (E359K; DN-ILK), was a kind gift of Dr Shoukat Dedhar (University of British Columbia, Vancouver, British Columbia). Adherent and subconfluent cultures were transfected with 0-20 mg of the plasmid using Lipofectin (Invitrogen). The total amount of cDNA introduced was held constant at 20 mg by varying the amount of the control (empty) plasmid included in the mixture with Lipofectin.
Immunoblot analysis
Immunoblots were performed as described previously (Wescott et al., 1998) . Antibodies purchased from Santa Cruz Biotechnology were raised against Akt (B-1), cyclin D1 (72-13G), c-Myc (C-19), E-cadherin (G-10), ERK1/2 (K-23), PKCa (sc208), PKCe (C-15), and RACK1 (B-3). Antibodies against phosphorylated-Akt (Thr308), phosphorylated-Akt (Ser473), phosphorylated-GSK-3b (Ser9), or PTEN (26H9) were purchased from Cell Signaling (Beverly, MA, USA). Anti-b-catenin (clone 14), GSK-3b (clone 7), ILK (3), and Src (GD11) antibodies were purchased from BD Transduction Laboratories (San Diego, CA, USA). Anti-talin antibody (8d4) was purchased from Sigma. Anti-b-actin antibody (JLA20) was purchased from Oncogene Research (Boston, MA, USA).
Preparation of nuclear extracts
Nuclear extracts were prepared essentially according to the method of Dignam et al. (1983) , with minor modifications. Subconfluent cultures were trypsinized and washed with PBS. Cells were collected by centrifugation and resuspended in buffer A (10 mM NaOH-Hepes, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5% NP-40, and 0.5 mM phenylmethysulfonyl fluoride (PMSF)) and incubated on ice for 30 min. This suspension was centrifuged for 5 min at 800 g and 41C before washing pellets twice using buffer B (10 mM NaOH-Hepes, pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, and 0.5 mM PMSF). The pellets were then suspended in buffer C (20 mM NaOH-Hepes, pH 7.9, 10% glycerol, 420 mM NaCl, 1.5 mM EDTA, and 0.5 mM PMSF) and incubated on ice for 45 min. These lysates were centrifuged for 5 min at 10 000 g and 41C and the resulting supernatants were analysed as nuclear fractions.
Immunoprecipitation
Cells (2 Â 10 7 ) were sonicated (5 s) and extracted in lysis buffer (150 mM NaCl, 1% IGEPAL CA-630, 50 mM Tris, pH 8.0, and 1 mM PMSF). Cell lysates were centrifuged at 12 000 g and the supernatants were precleared with Protein A Sepharose 4 Fast Flow beads (Pharmacia) and antibodies against b1 integrin, ILK, PKB/Akt, PKCe, or Src were added to a final concentration of 10 mg/ml of lysate. Immunoprecipitates (IPs) were washed twice and analysed by SDS-PAGE as previously described .
TOP-Flash/FOP-Flash reporter assays
Cells were cultured on 12-well plates for 24 h before transfection. Cells were transfected in triplicate with 0.5 mg of the reporter plasmid pTOP-Flash or mutated control pFOP-Flash (Upstate, Charlottesville, VA, USA) and 0.25 mg of pTK-RL as an internal control (Promega, Madison, WI, USA). At 48 h after transfection, cell lysates were assayed for luciferase activity using a Dual-Luciferase Assay system (Promega). Luminescence was measured using the Femtomaster FB12 single tube luminometer (Zylux, Oak Ridge, TN, USA). Luciferase activity was normalized for transfection efficiency by Renilla luciferase activity. Relative TCF activity was defined as the ratio of luciferase activity in cells transfected with TOP-Flash versus FOP-Flash reporter plasmids.
Data analysis
Values shown are representative of three or more experiments, unless otherwise specified, and treatment effects were evaluated using a two-sided Student's t-test. Errors are s.e. values of averaged results, and values of Po0.05 were taken as a significant difference between means.
